Le Lézard13h
Glidian Joins Infinx to Advance Prior Authorization Automation and Expand Market Reach
CUPERTINO, CALIFORNIA / ACCESS Newswire / March 17, 2025 / Infinx, a leader in AI-powered revenue cycle management solutions, announces the acquisition of Glidian, a market leader in prior ...
Infinx Healthcare: Glidian Joins Infinx to Advance Prior Authorization Automation and Expand Market Reach
CUPERTINO, CALIFORNIA / ACCESS Newswire / March 17, 2025 / Infinx, a leader in AI-powered revenue cycle management solutions, announces the acquisition of Glidian, a market leader in prior authorizati ...
VITRAKVI Maintains Market Leadership Across the 7MM Amid Growing TRK Inhibitor Competition | DelveInsight
DelveInsight's "VITRAKVI Market Size, Forecast, and Market Insight Report" highlights the details around VITRAKVI, a TRK, ...
BenefitsPRO9h
Serious about cutting federal spending? Here’s an easy one—no chainsaw needed
Restricting the forced early applications to the Social Security disability benefits program is a common-sense reform and ...
The Commonwealth Fund13h
What Pharmacy Benefit Managers Do, and How They Contribute to Drug Spending
Policymakers at the federal and state level have considered a number of reforms, many of which have bipartisan support, to ...
Collegium Announces Updates to its Board of Directors and Executive Leadership Team
Gino Santini Appointed as Chairman of the Board, Michael Heffernan, Founder and Chairman and Gwen A. Melincoff, Board Member to Retire ...
DelveInsight Business Research, LLP: VITRAKVI Maintains Market Leadership Across the 7MM Amid Growing TRK Inhibitor Competition | DelveInsight
VITRAKVI has strong market potential as a first-in-class TRK inhibitor for patients with NTRK gene fusion-positive cancers, regardless of tumor type. The growing adoption of precision oncology ...